🔗 Share this article

Texas Attorney General Ken Paxton is suing the producers of acetaminophen, claiming the companies withheld safety concerns that the medication posed to children's brain development.

The court filing follows a month after Former President Trump promoted an unsubstantiated connection between using acetaminophen - alternatively called acetaminophen - while pregnant and autism spectrum disorder in children.

The attorney general is suing J&J, which previously sold the medication, the only pain reliever approved for women during pregnancy, and Kenvue, which now manufacturers it.

In a statement, he stated they "betrayed America by gaining financially from discomfort and marketing drugs without regard for the potential hazards."

The manufacturer asserts there is no credible evidence connecting Tylenol to autism.

"These companies misled for generations, intentionally threatening millions to increase profits," Paxton, from the Republican party, declared.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the safety of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its online platform, the company also said it had "consistently assessed the applicable studies and there is no credible data that demonstrates a established connection between consuming paracetamol and autism spectrum disorder."

Organizations speaking for doctors and healthcare providers concur.

ACOG has said acetaminophen - the key substance in Tylenol - is one of the few options for pregnant women to treat discomfort and elevated temperature, which can present major wellness concerns if left untreated.

"In more than two decades of studies on the consumption of acetaminophen in gestation, zero credible investigations has conclusively proven that the usage of paracetamol in any trimester of pregnancy results in brain development issues in young ones," the group stated.

The court filing mentions current declarations from the Trump administration in claiming the drug is potentially dangerous.

Last month, Trump caused concern from public health officials when he advised expectant mothers to "resist strongly" not to consume acetaminophen when ill.

The FDA then published an announcement that physicians should consider limiting the consumption of acetaminophen, while also declaring that "a proven link" between the medication and autism in young ones has not been established.

The Health Department head Kennedy, who supervises the FDA, had vowed in spring to initiate "extensive scientific investigation" that would establish the origin of autism spectrum disorder in a limited time.

But authorities cautioned that discovering a unique factor of autism - thought by researchers to be the outcome of a complex mix of inherited and environmental factors - would prove challenging.

Autism is a type of permanent neurological difference and condition that impacts how individuals experience and engage with the environment, and is recognized using physician assessments.

In his legal document, Paxton - who supports Trump who is campaigning for the Senate - claims the manufacturer and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.

This legal action seeks to make the corporations "eliminate any marketing or advertising" that asserts acetaminophen is secure for women during pregnancy.

This legal action mirrors the grievances of a collection of mothers and fathers of children with autism and attention deficit hyperactivity disorder who sued the makers of acetaminophen in recently.

Judicial authorities dismissed the case, declaring research from the parents' expert witnesses was lacking definitive proof.